drugset / Trial / NCT03878082

Propacetamol to Reduce Post Cesarean Section Uterine Contraction Pain

NCT03878082

Completed 100 enrolled Mackay Memorial Hospital
RandomizedParallel-groupDouble-blindTreatment

Summary

To evaluate that perioperative regular usage of propacetamol to reduce post cesarean section uterine contraction pain and opioid consumption

Timeline

Start
2019-08-12
Primary completion
2022-12-30
Completion
2022-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propacetamol Small molecule 1 g Intravenous
Comparator Propacetamol Small molecule 2 g Intravenous

Indications